Latest News

Ibalizumab Demonstrates Promising Results in Phase 3 Trial for Multidrug Resistant HIV
Long-acting antiretroviral maintains significant viral load reduction and increases CD4+ T cells in HIV.
Flawed patents challenged on blockbuster HCV drugs to allow generic production.
SMAC mimetics and immune checkpoint inhibitors, together, promote tumor immunity against deadly brain cancer.
The American Diabetes Association releases an update position statement reflecting the current diabetic neuropathy landscape.
Findings suggest that human genetics trigger mutations in the HIV viral genome.
Biosimilar costs 15% less than the reference product.
Top news of the day from across the health care landscape.
Review the new products and expanded indications approved by the FDA in January 2017.

Features

Medical Benefit Specialty Drug Management–A Call to Action
Specialty drug trend management typically focuses on drug formulations administered via a payer or plan sponsor pharmacy benefit, which overlooks drug spending occurring under a payer or plan sponsor medical benefit.
Current stage 3 trials for multiple sclerosis medications may address several unmet needs in the patient population.
Specialty pharmacies that offer effective medication therapy management and support are best suited to serve as arbiters of the next generation of value-based contracts.
If direct and indirect remuneration fees are to remain, the health care system must recognize that specialty pharmacies provide different services to patients.

Featured Company Profile

 
MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy

Videos

Eric Peacock, CEO of MyHealthTeams, discusses how the role patients take in their own care is rapidly evolving in the technological era.

Daniel P. Kus, BS Pharm, RPh, discusses how specialty pharmacies can help patients manage out-of-pocket drug spending.

Sheila Arquette, RPh, discusses the importance of obtaining accreditation for specialty pharmacy.

Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.

Previous TabNext Tab
Strategic Alliance Partners
$AD300x250BB$
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
HCPLive
ONCLive
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Intellisphere, LLC. All Rights Reserved.
 

$vacMongoViewPlus$